论文部分内容阅读
目的:观察个体化治疗原发性肝癌的临床效果。方法:对我院收治的50例原发性肝癌患者予以个体化治疗的临床资料进行回顾性分析。结果:本组50例原发性肝癌患者完全缓解9例、部分缓解17例、无变化13例、病变进展11例,总有效率为52.0%;部分患者出现不良反应,经对症治疗后均未影响治疗计划;经随访,本组患者1年生存率及2年生存率分别62.0%、46.0%。结论:有机结合患者具体病情及各种治疗方式的优缺点,对原发性肝癌患者予以个体化治疗具有较高临床应用推广价值。
Objective: To observe the clinical effect of individualized treatment of primary liver cancer. Methods: The clinical data of 50 patients with primary liver cancer treated in our hospital were retrospectively analyzed. Results: The group of 50 cases of primary liver cancer patients were completely relieved in 9 cases, partial response in 17 cases, no change in 13 cases, 11 cases of pathological changes, the total effective rate was 52.0%; some patients had adverse reactions, after symptomatic treatment were not Affect the treatment plan; after follow-up, the 1-year survival rate and 2-year survival rate of patients were 62.0%, 46.0%. Conclusion: The combination of patients with specific conditions and the advantages and disadvantages of various treatment methods, personalized treatment of patients with primary liver cancer has a higher clinical application of promotional value.